Inhalable insulin play Dance files for IPO

Dance Biopharm Inc. (Brisbane, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Wells Fargo; Stifel; Oppenheimer; and Roth Capital Partners. Dance is developing Dance 501 (...